Table 3 Inhaled off-label medicinal products including EMDs in their composition.

From: Assessment of mandatory declaration excipients in pediatric off label prescriptions in Spain

Medicinal product

Number of prescriptions (% of total) *

ATC code

EMD

EMD quantity on SmPC

Budesonide 100 mcg inhalator

78,435 (1.6%)

R01A - Decongestants and other nasal preparations for topical use

R01AD - Corticosteroids

R01AD05 - Budesonide

Ethanol

0.5 mg/inhalation

Budesonide 200 mcg inhalator

246,942

(5%)

Ethanol

0.5 mg/inhalation

Formoterol and budesonide 160 mcg/4.5 mcg inhalator

1,419

(< 1%)

Lactose

730 mcg/inhalation

  1. Notes: *Considering total off-label prescriptions analysed = 4,922,984. Calculation of % of total = [Number of prescriptions by medicinal product/Total number of off-label prescriptions] *100; Degree of harm of EMDs for pediatric individuals split into 3 categories, being “low” (white rows), “moderate” (light grey rows), and ”severe” (dark grey rows) | Abbreviations: ATC: Anatomical Therapeutic Chemical Classification System; EMD: Excipient of mandatory declaration; mcg: Microgram; mg: Milligram; SmPC: Summary of Product Characteristics | Sources6,8,11,12:.
Back to article page